Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Ellenbroek

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|May 8, 2013
Histamine H₃ receptors, the complex interaction with dopamine and its implications for addictionB A Ellenbroek
Behavioural Pharmacology|September 23, 2003
Animal models in the genomic era: possibilities and limitations with special emphasis on schizophreniaB A Ellenbroek
Pharmacology & Therapeutics|January 1, 1993
Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugsB A Ellenbroek
Acta Neuropsychiatrica|March 16, 2016
Behavioural genetics: An introductionF Sluyter, B A Ellenbroek
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
The long-term effects of maternal deprivation depend on the genetic backgroundB A Ellenbroek, A R Cools
Acta Neuropsychiatrica|March 10, 2016
Neuroleptics: preclinical and clinical differencesB A Ellenbroek, A R Cools
Behavioural Pharmacology|December 5, 2000
Animal models for the negative symptoms of schizophreniaB A Ellenbroek, A R Cools
Clinical Neuropharmacology|January 1, 1992
Interaction between aminergic systems in mesolimbic structures: the importance of 5-HT2, D2 and D1 receptors in the olfactory tubercle for the atypical profile of neurolepticsA R Cools, E Prinssen, B A Ellenbroek
Neuroscience|November 1, 1996
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortexB A Ellenbroek, S Budde, A R Cools
Psychopharmacology|February 9, 2000
The role of genetic and early environmental factors in determining apomorphine susceptibilityB A Ellenbroek, F Sluyter, A R Cools
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|May 8, 2013
Histamine H₃ receptors, the complex interaction with dopamine and its implications for addictionB A Ellenbroek
Behavioural Pharmacology|September 23, 2003
Animal models in the genomic era: possibilities and limitations with special emphasis on schizophreniaB A Ellenbroek
Pharmacology & Therapeutics|January 1, 1993
Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugsB A Ellenbroek
Acta Neuropsychiatrica|March 16, 2016
Behavioural genetics: An introductionF Sluyter, B A Ellenbroek
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
The long-term effects of maternal deprivation depend on the genetic backgroundB A Ellenbroek, A R Cools
Acta Neuropsychiatrica|March 10, 2016
Neuroleptics: preclinical and clinical differencesB A Ellenbroek, A R Cools
Behavioural Pharmacology|December 5, 2000
Animal models for the negative symptoms of schizophreniaB A Ellenbroek, A R Cools
Clinical Neuropharmacology|January 1, 1992
Interaction between aminergic systems in mesolimbic structures: the importance of 5-HT2, D2 and D1 receptors in the olfactory tubercle for the atypical profile of neurolepticsA R Cools, E Prinssen, B A Ellenbroek
Neuroscience|November 1, 1996
Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortexB A Ellenbroek, S Budde, A R Cools
Psychopharmacology|February 9, 2000
The role of genetic and early environmental factors in determining apomorphine susceptibilityB A Ellenbroek, F Sluyter, A R Cools
Pageof 6